Nova Medical (United States)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
2022 · Josef S Smolen, Robert Landewé, et al. · Annals of the Rheumatic Diseases
Angiotensin II for the Treatment of Vasodilatory Shock
2017 · Ashish K. Khanna, Shane English, et al. · New England Journal of Medicine
Correction: Corrigendum: Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells
2015 · Ana da Rosa Soares, Tânia Martins‐Marques, et al. · Scientific Reports